Spread the Word:

Webinar: Understanding the Role Biologics & Biosimilars Can Play in Healthcare

Nov 17

1 p.m. ET


There are many biologic medicines available to patients to help manage inflammatory conditions and cancer.

What you have available often depends on your disease progression, your insurance carrier, the out of pocket costs you are responsible for, as well as shared decision making between you and your doctor.

Many of the biologic medicines available for inflammatory conditions and cancer have biosimilars now available. This is great news for patients as it adds competition to the market, which could mean lower costs.
It’s important for patients to have an understanding of biosimilars and to learn from the patients who have been there, as well as the doctors who are prescribing them.

Join us for this free webinar to learn more about biologics and biosimilars. For many the knowledge level is minimal and you are being asked to think about moving onto these medications or maybe switching from one to another. This webinar can help you navigate the landscape and provide resources to get even more information.

And – you can ask your questions!

Topics to be discussed are:

  • What is a biosimilar and how do they differ from other name brand biologics?
  • Hear from a doctor on how she talks with her patients about biosimilars.
  • Learn from real patients how they talk to their doctor about biosimilars.
  • Hear from real patients about what they experienced
  • Ask your questions during the Q&A

This webinar will also be live streamed on Facebook. All registrants will receive the free E-Book, Biologics and Biosimilars.

Register Today

 


Speakers

 

Madelaine A. Feldman, M.D. FACR

Dr. Madelaine Feldman is a rheumatologist in private practice with The Rheumatology Group in New Orleans, LA. She is President of the Coalition of State Rheumatology Organizations, Chair of the Alliance for Safe Biologic Medicines and past member of the American College of Rheumatology insurance subcommittee.  

Dr. Feldman is a Clinical Assistant Professor of Medicine at Tulane University School of Medicine, and lectures extensively to patients, physicians, regulators, and legislators both locally and nationally, speaking before the Health subcommittee of Energy and Commerce in 2019.   She has spoken and written on the  drug supply channel, particularly the effect that formulary construction and utilization management tools have on pricing and access to drugs (availability & affordability.) 

Dr. Feldman received the Distinguished Service Award for Tulane Medical School, was named one of the Top Women in New Orleans by City Business in 2017 and is the former radio talk show host of “Driving with Dr. Mattie.” 

 

Chad Pettit 

As Executive Director, Global Value Access and Policy for Amgen’s Biosimilars Business Unit, Chad Pettit develops global market access launch strategy for Amgen’s portfolio of 10 biosimilar medicines. He serves as a liaison with the biopharmaceutical industry on policy matters in biosimilars, a rapidly growing segment of the Amgen business. With his global perspective, Chad is recognized as an expert on biosimilar commercialization, market access for biosimilars, and the policy measures required to facilitate cost savings for patients and the health care system over the long-run.

 

Terry Wilcox

As the Co-founder and Executive Director of Patients Rising, Terry helps patients find their voice and become outspoken advocates for their health care. She manages all of the day to day operations for the organization and is the visionary behind all of Patients Rising’s programs, including: Patients Rising University (education), Patients Rising Concierge (support), Institute for Patient Access & Affordability Project (research), and the policy and advocacy work of Patients Rising Now. She has a track record of building coalitions with patients, caregivers, and medical professionals. A regular opinion writer on health policy and how it affects patients, she has been published in the Boston Globe, The Hill, Morning Consult, Crains NY, Real Clear Health, the American Thinker, and more. Terry’s career in patient advocacy was inspired by her mentor Selma Schimmel, considered by many as the “original” young adult survivor advocate.

 

Kenzie K. Libbesmeier

Kenzie is the writer, public speaker, and advocate behind Be The Cactus Kenz – a website/blog formerly known as Life According to Kenz. After being diagnosed with juvenile idiopathic arthritis at the age of 14, she discovered a passion + purpose for raising her voice (and awareness!) for other young people affected by autoimmune disease. Kenzie currently resides in Minnesota with her boyfriend L and standard poodle Ophelia. She is a full-time licensed social worker who is determined to live a full and vibrant life amidst the complexities associated with battling rheumatoid arthritis, Crohn’s disease, and Addison’s disease

 

Britta Bloomquist

Britta Bloomquist has been a proud member of the epatient community for over 15 years. In 2013, Bloomquist was diagnosed with AnkylosingSpondylitis after 20 years of visiting specialists. She has participated as an ePatient Scholar at Stanford Medicine X in 2015, 2017, and 2019, presented on patient portals at The Office of the National Coordinator for Health Information Technology in 2019, is a former advisor for the National IT PFCCPartners PFAC, and has served on many local boards and committees. In her free time, she enjoys
reading memoirs and medical journals, promoting the benefits of the patient portal, working on her meditation practice, spending time outdoors, and laughing. She resides in Duluth, MN with her partner and their two cats.

 

 Register Today


Spread the Word:

You'll receive updates about new resources, patient stories and insights, advocacy work, and alerts about patient-support events.
The latest about patient advocacy

Join our Email List

Get notified about new stories and resources to empower patients and caregivers.